Industry Research Reports
Home > Reports > Service & Software > Global Cold Chain Services for Innovative Drug Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Cold Chain Services for Innovative Drug Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-08-05
Pages: 136 Pages
Report ld: 4858199
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Cold Chain Services for Innovative Drug market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Cold chain services for innovative drug development refer to temperature-controlled transportation and storage solutions specifically designed for temperature-sensitive drugs, samples, or reagents during the drug development process. These services ensure that drugs and related materials under research maintain optimal temperature conditions throughout the logistics process, preventing any compromise in their activity, stability, or quality due to external temperature fluctuations. The service typically includes refrigerated, frozen, and ultra-low temperature storage, and is applicable to clinical trials, laboratory research, and drug manufacturing.
From a downstream perspective, Pharmaceutical Companies accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Cold Chain Services for Innovative Drug leading manufacturers including Marken, World Courier, Cryoport, DTW Logistics, City Express, Shanghai Shengsheng Pharmaceutical Cold Chain Technology, Thermo Fisher, SF Express, Catalent, CIMC Cold Cloud, etc., dominate supply; the top five capture approximately % of global revenue, with Marken leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Cold Chain Services for Innovative Drug market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Marken
- World Courier
- Cryoport
- DTW Logistics
- City Express
- Shanghai Shengsheng Pharmaceutical Cold Chain Technology
- Thermo Fisher
- SF Express
- Catalent
- CIMC Cold Cloud
- Guoyuan Life Sciences Group
- Rochin Logistics
- Azenta
- Saroute
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- International Transportation
- Domestic Transportation
Segment by Application
- Pharmaceutical Companies
- Hospitals
- Laboratories
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Cold Chain Services for Innovative Drug study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Cold Chain Services for Innovative Drug: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Cold Chain Services for Innovative Drug Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 International Transportation
1.2.3 Domestic Transportation
1.3 Market Segmentation by Application
1.3.1 Global Cold Chain Services for Innovative Drug Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Hospitals
1.3.4 Laboratories
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cold Chain Services for Innovative Drug Revenue Estimates and Forecasts 2020-2031
2.2 Global Cold Chain Services for Innovative Drug Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Cold Chain Services for Innovative Drug Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Cold Chain Services for Innovative Drug Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 International Transportation Market Size by Players
3.3.2 Domestic Transportation Market Size by Players
3.4 Global Cold Chain Services for Innovative Drug Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Cold Chain Services for Innovative Drug Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Cold Chain Services for Innovative Drug Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Cold Chain Services for Innovative Drug Market Size by Type (2020-2031)
6.4 North America Cold Chain Services for Innovative Drug Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Cold Chain Services for Innovative Drug Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Cold Chain Services for Innovative Drug Market Size by Type (2020-2031)
7.4 Europe Cold Chain Services for Innovative Drug Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Cold Chain Services for Innovative Drug Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Cold Chain Services for Innovative Drug Market Size by Type (2020-2031)
8.4 Asia-Pacific Cold Chain Services for Innovative Drug Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Cold Chain Services for Innovative Drug Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Cold Chain Services for Innovative Drug Market Size by Type (2020-2031)
9.4 Central and South America Cold Chain Services for Innovative Drug Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Cold Chain Services for Innovative Drug Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Cold Chain Services for Innovative Drug Market Size by Type (2020-2031)
10.4 Middle East and Africa Cold Chain Services for Innovative Drug Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Cold Chain Services for Innovative Drug Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Marken
11.1.1 Marken Corporation Information
11.1.2 Marken Business Overview
11.1.3 Marken Cold Chain Services for Innovative Drug Product Features and Attributes
11.1.4 Marken Cold Chain Services for Innovative Drug Revenue and Gross Margin (2020-2025)
11.1.5 Marken Cold Chain Services for Innovative Drug Revenue by Product in 2024
11.1.6 Marken Cold Chain Services for Innovative Drug Revenue by Application in 2024
11.1.7 Marken Cold Chain Services for Innovative Drug Revenue by Geographic Area in 2024
11.1.8 Marken Cold Chain Services for Innovative Drug SWOT Analysis
11.1.9 Marken Recent Developments
11.2 World Courier
11.2.1 World Courier Corporation Information
11.2.2 World Courier Business Overview
11.2.3 World Courier Cold Chain Services for Innovative Drug Product Features and Attributes
11.2.4 World Courier Cold Chain Services for Innovative Drug Revenue and Gross Margin (2020-2025)
11.2.5 World Courier Cold Chain Services for Innovative Drug Revenue by Product in 2024
11.2.6 World Courier Cold Chain Services for Innovative Drug Revenue by Application in 2024
11.2.7 World Courier Cold Chain Services for Innovative Drug Revenue by Geographic Area in 2024
11.2.8 World Courier Cold Chain Services for Innovative Drug SWOT Analysis
11.2.9 World Courier Recent Developments
11.3 Cryoport
11.3.1 Cryoport Corporation Information
11.3.2 Cryoport Business Overview
11.3.3 Cryoport Cold Chain Services for Innovative Drug Product Features and Attributes
11.3.4 Cryoport Cold Chain Services for Innovative Drug Revenue and Gross Margin (2020-2025)
11.3.5 Cryoport Cold Chain Services for Innovative Drug Revenue by Product in 2024
11.3.6 Cryoport Cold Chain Services for Innovative Drug Revenue by Application in 2024
11.3.7 Cryoport Cold Chain Services for Innovative Drug Revenue by Geographic Area in 2024
11.3.8 Cryoport Cold Chain Services for Innovative Drug SWOT Analysis
11.3.9 Cryoport Recent Developments
11.4 DTW Logistics
11.4.1 DTW Logistics Corporation Information
11.4.2 DTW Logistics Business Overview
11.4.3 DTW Logistics Cold Chain Services for Innovative Drug Product Features and Attributes
11.4.4 DTW Logistics Cold Chain Services for Innovative Drug Revenue and Gross Margin (2020-2025)
11.4.5 DTW Logistics Cold Chain Services for Innovative Drug Revenue by Product in 2024
11.4.6 DTW Logistics Cold Chain Services for Innovative Drug Revenue by Application in 2024
11.4.7 DTW Logistics Cold Chain Services for Innovative Drug Revenue by Geographic Area in 2024
11.4.8 DTW Logistics Cold Chain Services for Innovative Drug SWOT Analysis
11.4.9 DTW Logistics Recent Developments
11.5 City Express
11.5.1 City Express Corporation Information
11.5.2 City Express Business Overview
11.5.3 City Express Cold Chain Services for Innovative Drug Product Features and Attributes
11.5.4 City Express Cold Chain Services for Innovative Drug Revenue and Gross Margin (2020-2025)
11.5.5 City Express Cold Chain Services for Innovative Drug Revenue by Product in 2024
11.5.6 City Express Cold Chain Services for Innovative Drug Revenue by Application in 2024
11.5.7 City Express Cold Chain Services for Innovative Drug Revenue by Geographic Area in 2024
11.5.8 City Express Cold Chain Services for Innovative Drug SWOT Analysis
11.5.9 City Express Recent Developments
11.6 Shanghai Shengsheng Pharmaceutical Cold Chain Technology
11.6.1 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Corporation Information
11.6.2 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Business Overview
11.6.3 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Cold Chain Services for Innovative Drug Product Features and Attributes
11.6.4 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Cold Chain Services for Innovative Drug Revenue and Gross Margin (2020-2025)
11.6.5 Shanghai Shengsheng Pharmaceutical Cold Chain Technology Recent Developments
11.7 Thermo Fisher
11.7.1 Thermo Fisher Corporation Information
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher Cold Chain Services for Innovative Drug Product Features and Attributes
11.7.4 Thermo Fisher Cold Chain Services for Innovative Drug Revenue and Gross Margin (2020-2025)
11.7.5 Thermo Fisher Recent Developments
11.8 SF Express
11.8.1 SF Express Corporation Information
11.8.2 SF Express Business Overview
11.8.3 SF Express Cold Chain Services for Innovative Drug Product Features and Attributes
11.8.4 SF Express Cold Chain Services for Innovative Drug Revenue and Gross Margin (2020-2025)
11.8.5 SF Express Recent Developments
11.9 Catalent
11.9.1 Catalent Corporation Information
11.9.2 Catalent Business Overview
11.9.3 Catalent Cold Chain Services for Innovative Drug Product Features and Attributes
11.9.4 Catalent Cold Chain Services for Innovative Drug Revenue and Gross Margin (2020-2025)
11.9.5 Catalent Recent Developments
11.10 CIMC Cold Cloud
11.10.1 CIMC Cold Cloud Corporation Information
11.10.2 CIMC Cold Cloud Business Overview
11.10.3 CIMC Cold Cloud Cold Chain Services for Innovative Drug Product Features and Attributes
11.10.4 CIMC Cold Cloud Cold Chain Services for Innovative Drug Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Guoyuan Life Sciences Group
11.11.1 Guoyuan Life Sciences Group Corporation Information
11.11.2 Guoyuan Life Sciences Group Business Overview
11.11.3 Guoyuan Life Sciences Group Cold Chain Services for Innovative Drug Product Features and Attributes
11.11.4 Guoyuan Life Sciences Group Cold Chain Services for Innovative Drug Revenue and Gross Margin (2020-2025)
11.11.5 Guoyuan Life Sciences Group Recent Developments
11.12 Rochin Logistics
11.12.1 Rochin Logistics Corporation Information
11.12.2 Rochin Logistics Business Overview
11.12.3 Rochin Logistics Cold Chain Services for Innovative Drug Product Features and Attributes
11.12.4 Rochin Logistics Cold Chain Services for Innovative Drug Revenue and Gross Margin (2020-2025)
11.12.5 Rochin Logistics Recent Developments
11.13 Azenta
11.13.1 Azenta Corporation Information
11.13.2 Azenta Business Overview
11.13.3 Azenta Cold Chain Services for Innovative Drug Product Features and Attributes
11.13.4 Azenta Cold Chain Services for Innovative Drug Revenue and Gross Margin (2020-2025)
11.13.5 Azenta Recent Developments
11.14 Saroute
11.14.1 Saroute Corporation Information
11.14.2 Saroute Business Overview
11.14.3 Saroute Cold Chain Services for Innovative Drug Product Features and Attributes
11.14.4 Saroute Cold Chain Services for Innovative Drug Revenue and Gross Margin (2020-2025)
11.14.5 Saroute Recent Developments
12 Cold Chain Services for Innovative DrugIndustry Chain Analysis
12.1 Cold Chain Services for Innovative Drug Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Cold Chain Services for Innovative Drug Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Cold Chain Services for Innovative Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Cold Chain Services for Innovative Drug Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Cold Chain Services for Innovative Drug Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Cold Chain Services for Innovative Drug Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Cold Chain Services for Innovative Drug Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Cold Chain Services for Innovative Drug Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Cold Chain Services for Innovative Drug Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Cold Chain Services for Innovative Drug Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Cold Chain Services for Innovative Drug by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Chain Services for Innovative Drug as of 2024)
Table 11. Global Cold Chain Services for Innovative Drug Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Cold Chain Services for Innovative Drug Companies Headquarters
Table 13. Global Cold Chain Services for Innovative Drug Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Cold Chain Services for Innovative Drug Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Cold Chain Services for Innovative Drug Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Cold Chain Services for Innovative Drug Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Cold Chain Services for Innovative Drug Revenue by Application (2026-2031) & (US$ Million)
Table 21. Cold Chain Services for Innovative Drug High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Cold Chain Services for Innovative Drug Growth Accelerators and Market Barriers
Table 25. North America Cold Chain Services for Innovative Drug Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Cold Chain Services for Innovative Drug Growth Accelerators and Market Barriers
Table 27. Europe Cold Chain Services for Innovative Drug Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Cold Chain Services for Innovative Drug Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Cold Chain Services for Innovative Drug Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Cold Chain Services for Innovative Drug Investment Opportunities and Key Challenges
Table 31. Central and South America Cold Chain Services for Innovative Drug Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Cold Chain Services for Innovative Drug Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Cold Chain Services for Innovative Drug Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Marken Corporation Information
Table 35. Marken Description and Major Businesses
Table 36. Marken Product Features and Attributes
Table 37. Marken Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Marken Revenue Proportion by Product in 2024
Table 39. Marken Revenue Proportion by Application in 2024
Table 40. Marken Revenue Proportion by Geographic Area in 2024
Table 41. Marken Cold Chain Services for Innovative Drug SWOT Analysis
Table 42. Marken Recent Developments
Table 43. World Courier Corporation Information
Table 44. World Courier Description and Major Businesses
Table 45. World Courier Product Features and Attributes
Table 46. World Courier Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. World Courier Revenue Proportion by Product in 2024
Table 48. World Courier Revenue Proportion by Application in 2024
Table 49. World Courier Revenue Proportion by Geographic Area in 2024
Table 50. World Courier Cold Chain Services for Innovative Drug SWOT Analysis
Table 51. World Courier Recent Developments
Table 52. Cryoport Corporation Information
Table 53. Cryoport Description and Major Businesses
Table 54. Cryoport Product Features and Attributes
Table 55. Cryoport Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Cryoport Revenue Proportion by Product in 2024
Table 57. Cryoport Revenue Proportion by Application in 2024
Table 58. Cryoport Revenue Proportion by Geographic Area in 2024
Table 59. Cryoport Cold Chain Services for Innovative Drug SWOT Analysis
Table 60. Cryoport Recent Developments
Table 61. DTW Logistics Corporation Information
Table 62. DTW Logistics Description and Major Businesses
Table 63. DTW Logistics Product Features and Attributes
Table 64. DTW Logistics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. DTW Logistics Revenue Proportion by Product in 2024
Table 66. DTW Logistics Revenue Proportion by Application in 2024
Table 67. DTW Logistics Revenue Proportion by Geographic Area in 2024
Table 68. DTW Logistics Cold Chain Services for Innovative Drug SWOT Analysis
Table 69. DTW Logistics Recent Developments
Table 70. City Express Corporation Information
Table 71. City Express Description and Major Businesses
Table 72. City Express Product Features and Attributes
Table 73. City Express Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. City Express Revenue Proportion by Product in 2024
Table 75. City Express Revenue Proportion by Application in 2024
Table 76. City Express Revenue Proportion by Geographic Area in 2024
Table 77. City Express Cold Chain Services for Innovative Drug SWOT Analysis
Table 78. City Express Recent Developments
Table 79. Shanghai Shengsheng Pharmaceutical Cold Chain Technology Corporation Information
Table 80. Shanghai Shengsheng Pharmaceutical Cold Chain Technology Description and Major Businesses
Table 81. Shanghai Shengsheng Pharmaceutical Cold Chain Technology Product Features and Attributes
Table 82. Shanghai Shengsheng Pharmaceutical Cold Chain Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Shanghai Shengsheng Pharmaceutical Cold Chain Technology Recent Developments
Table 84. Thermo Fisher Corporation Information
Table 85. Thermo Fisher Description and Major Businesses
Table 86. Thermo Fisher Product Features and Attributes
Table 87. Thermo Fisher Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Thermo Fisher Recent Developments
Table 89. SF Express Corporation Information
Table 90. SF Express Description and Major Businesses
Table 91. SF Express Product Features and Attributes
Table 92. SF Express Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. SF Express Recent Developments
Table 94. Catalent Corporation Information
Table 95. Catalent Description and Major Businesses
Table 96. Catalent Product Features and Attributes
Table 97. Catalent Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Catalent Recent Developments
Table 99. CIMC Cold Cloud Corporation Information
Table 100. CIMC Cold Cloud Description and Major Businesses
Table 101. CIMC Cold Cloud Product Features and Attributes
Table 102. CIMC Cold Cloud Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. CIMC Cold Cloud Recent Developments
Table 104. Guoyuan Life Sciences Group Corporation Information
Table 105. Guoyuan Life Sciences Group Description and Major Businesses
Table 106. Guoyuan Life Sciences Group Product Features and Attributes
Table 107. Guoyuan Life Sciences Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Guoyuan Life Sciences Group Recent Developments
Table 109. Rochin Logistics Corporation Information
Table 110. Rochin Logistics Description and Major Businesses
Table 111. Rochin Logistics Product Features and Attributes
Table 112. Rochin Logistics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Rochin Logistics Recent Developments
Table 114. Azenta Corporation Information
Table 115. Azenta Description and Major Businesses
Table 116. Azenta Product Features and Attributes
Table 117. Azenta Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Azenta Recent Developments
Table 119. Saroute Corporation Information
Table 120. Saroute Description and Major Businesses
Table 121. Saroute Product Features and Attributes
Table 122. Saroute Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Saroute Recent Developments
Table 124. Raw Materials Key Suppliers
Table 125. Distributors List
Table 126. Market Trends and Market Evolution
Table 127. Market Drivers and Opportunities
Table 128. Market Challenges, Risks, and Restraints
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Cold Chain Services for Innovative Drug Product Picture
Figure 2. Global Cold Chain Services for Innovative Drug Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. International Transportation Product Picture
Figure 4. Domestic Transportation Product Picture
Figure 5. Global Cold Chain Services for Innovative Drug Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Pharmaceutical Companies
Figure 7. Hospitals
Figure 8. Laboratories
Figure 9. Others
Figure 10. Cold Chain Services for Innovative Drug Report Years Considered
Figure 11. Global Cold Chain Services for Innovative Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 13. Global Cold Chain Services for Innovative Drug Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Cold Chain Services for Innovative Drug Revenue Market Share by Region (2020-2031)
Figure 15. Global Cold Chain Services for Innovative Drug Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. International Transportation Revenue Market Share by Player in 2024
Figure 18. Domestic Transportation Revenue Market Share by Player in 2024
Figure 19. Global Cold Chain Services for Innovative Drug Revenue Market Share by Type (2020-2031)
Figure 20. Global Cold Chain Services for Innovative Drug Revenue Market Share by Application (2020-2031)
Figure 21. North America Cold Chain Services for Innovative Drug Revenue YoY (2020-2031) & (US$ Million)
Figure 22. North America Top 5 Players Cold Chain Services for Innovative Drug Revenue (US$ Million) in 2024
Figure 23. North America Cold Chain Services for Innovative Drug Revenue (US$ Million) by Type (2020 - 2031)
Figure 24. North America Cold Chain Services for Innovative Drug Revenue (US$ Million) by Application (2020-2031)
Figure 25. US Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 26. Canada Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 27. Mexico Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 28. Europe Cold Chain Services for Innovative Drug Revenue YoY (2020-2031) & (US$ Million)
Figure 29. Europe Top 5 Players Cold Chain Services for Innovative Drug Revenue (US$ Million) in 2024
Figure 30. Europe Cold Chain Services for Innovative Drug Revenue (US$ Million) by Type (2020-2031)
Figure 31. Europe Cold Chain Services for Innovative Drug Revenue (US$ Million) by Application (2020-2031)
Figure 32. Germany Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 33. France Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 34. U.K. Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 35. Italy Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 36. Russia Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Cold Chain Services for Innovative Drug Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Top 8 Players Cold Chain Services for Innovative Drug Revenue (US$ Million) in 2024
Figure 39. Asia-Pacific Cold Chain Services for Innovative Drug Revenue (US$ Million) by Type (2020-2031)
Figure 40. Asia-Pacific Cold Chain Services for Innovative Drug Revenue (US$ Million) by Application (2020-2031)
Figure 41. Indonesia Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 42. Japan Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 43. South Korea Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 44. Australia Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 45. India Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 46. Indonesia Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 47. Vietnam Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 48. Malaysia Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 49. Philippines Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 50. Singapore Cold Chain Services for Innovative Drug Revenue (2020-2031) & (US$ Million)
Figure 51. Central and South America Cold Chain Services for Innovative Drug Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Central and South America Top 5 Players Cold Chain Services for Innovative Drug Revenue (US$ Million) in 2024
Figure 53. Central and South America Cold Chain Services for Innovative Drug Revenue (US$ Million) by Type (2020-2031)
Figure 54. Central and South America Cold Chain Services for Innovative Drug Revenue (US$ Million) by Application (2020-2031)
Figure 55. Brazil Cold Chain Services for Innovative Drug Revenue (2020-2025) & (US$ Million)
Figure 56. Argentina Cold Chain Services for Innovative Drug Revenue (2020-2025) & (US$ Million)
Figure 57. Middle East and Africa Cold Chain Services for Innovative Drug Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Middle East and Africa Top 5 Players Cold Chain Services for Innovative Drug Revenue (US$ Million) in 2024
Figure 59. South America Cold Chain Services for Innovative Drug Revenue (US$ Million) by Type (2020-2031)
Figure 60. Middle East and Africa Cold Chain Services for Innovative Drug Revenue (US$ Million) by Application (2020-2031)
Figure 61. GCC Countries Cold Chain Services for Innovative Drug Revenue (2020-2025) & (US$ Million)
Figure 62. Israel Cold Chain Services for Innovative Drug Revenue (2020-2025) & (US$ Million)
Figure 63. Egypt Cold Chain Services for Innovative Drug Revenue (2020-2025) & (US$ Million)
Figure 64. South Africa Cold Chain Services for Innovative Drug Revenue (2020-2025) & (US$ Million)
Figure 65. Cold Chain Services for Innovative Drug Industry Chain Mapping
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Cold Chain Services for Innovative Drug market?
The top companies in the global Cold Chain Services for Innovative Drug market are Marken、World Courier、Cryoport.
Related Reports
Global Cold Chain Services for Innovative Drug Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cold Chain Services for Innovative Drug market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 142
USD 4900.00
(Single User License)
Global Cold Chain Services for Innovative Drug Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cold Chain Services for Innovative Drug market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 95
USD 4250.00
(Single User License)
Cold Chain Services for Innovative Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cold Chain Services for Innovative Drug was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 120
USD 3950.00
(Single User License)
Global Cold Chain Services for Innovative Drug Market Research Report 2026
The global Cold Chain Services for Innovative Drug market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 117
USD 2900.00
(Single User License)
Global Cold Chain Services for Innovative Drug Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cold Chain Services for Innovative Drug market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 99
USD 4250.00
(Single User License)
Cold Chain Services for Innovative Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cold Chain Services for Innovative Drug was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 102
USD 3950.00
(Single User License)
Global Cold Chain Services for Innovative Drug Market Research Report 2025
The global market for Cold Chain Services for Innovative Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-12
Pages: 81
USD 2900.00
(Single User License)
Global Cold Chain Services for Innovative Drug Market Insights, Forecast to 2030
Cold chain services for innovative drug development refer to temperature-controlled transportation and storage solutions specifically designed for temperature-sensitive drugs, samples, or reagents during the drug development process. These services ensure that drugs and related materials under research maintain optimal temperature conditions throughout the logistics process, preventing any compromise in their activity, stability, or quality due to external temperature fluctuations. The service typically includes refrigerated, frozen, and ultra-low temperature storage, and is applicable to clinical trials, laboratory research, and drug manufacturing.
Published Date: 2024-09-28
Pages: 137
USD 4900.00
(Single User License)
Cold Chain Services for Innovative Drug- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Cold chain services for innovative drug development refer to temperature-controlled transportation and storage solutions specifically designed for temperature-sensitive drugs, samples, or reagents during the drug development process. These services ensure that drugs and related materials under research maintain optimal temperature conditions throughout the logistics process, preventing any compromise in their activity, stability, or quality due to external temperature fluctuations. The service typically includes refrigerated, frozen, and ultra-low temperature storage, and is applicable to clinical trials, laboratory research, and drug manufacturing.
Published Date: 2024-09-28
Pages: 115
USD 3950.00
(Single User License)
Global Cold Chain Services for Innovative Drug Market Research Report 2024
Cold chain services for innovative drug development refer to temperature-controlled transportation and storage solutions specifically designed for temperature-sensitive drugs, samples, or reagents during the drug development process. These services ensure that drugs and related materials under research maintain optimal temperature conditions throughout the logistics process, preventing any compromise in their activity, stability, or quality due to external temperature fluctuations. The service typically includes refrigerated, frozen, and ultra-low temperature storage, and is applicable to clinical trials, laboratory research, and drug manufacturing.
Published Date: 2024-09-28
Pages: 82
USD 2900.00
(Single User License)
Global Cold Chain Services for Innovative Drug Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Cold Chain Services for Innovative Drug market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 142
USD 4900.00 (Single User License)Global Cold Chain Services for Innovative Drug Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cold Chain Services for Innovative Drug market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 95
USD 4250.00 (Single User License)Cold Chain Services for Innovative Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cold Chain Services for Innovative Drug was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 120
USD 3950.00 (Single User License)Global Cold Chain Services for Innovative Drug Market Research Report 2026
The global Cold Chain Services for Innovative Drug market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 117
USD 2900.00 (Single User License)Global Cold Chain Services for Innovative Drug Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cold Chain Services for Innovative Drug market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 99
USD 4250.00 (Single User License)Cold Chain Services for Innovative Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cold Chain Services for Innovative Drug was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 102
USD 3950.00 (Single User License)Global Cold Chain Services for Innovative Drug Market Research Report 2025
The global market for Cold Chain Services for Innovative Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-12
Pages: 81
USD 2900.00 (Single User License)Global Cold Chain Services for Innovative Drug Market Insights, Forecast to 2030
Cold chain services for innovative drug development refer to temperature-controlled transportation and storage solutions specifically designed for temperature-sensitive drugs, samples, or reagents during the drug development process. These services ensure that drugs and related materials under research maintain optimal temperature conditions throughout the logistics process, preventing any compromise in their activity, stability, or quality due to external temperature fluctuations. The service typically includes refrigerated, frozen, and ultra-low temperature storage, and is applicable to clinical trials, laboratory research, and drug manufacturing.
Published: 2024-09-28
Pages: 137
USD 4900.00 (Single User License)Cold Chain Services for Innovative Drug- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Cold chain services for innovative drug development refer to temperature-controlled transportation and storage solutions specifically designed for temperature-sensitive drugs, samples, or reagents during the drug development process. These services ensure that drugs and related materials under research maintain optimal temperature conditions throughout the logistics process, preventing any compromise in their activity, stability, or quality due to external temperature fluctuations. The service typically includes refrigerated, frozen, and ultra-low temperature storage, and is applicable to clinical trials, laboratory research, and drug manufacturing.
Published: 2024-09-28
Pages: 115
USD 3950.00 (Single User License)Global Cold Chain Services for Innovative Drug Market Research Report 2024
Cold chain services for innovative drug development refer to temperature-controlled transportation and storage solutions specifically designed for temperature-sensitive drugs, samples, or reagents during the drug development process. These services ensure that drugs and related materials under research maintain optimal temperature conditions throughout the logistics process, preventing any compromise in their activity, stability, or quality due to external temperature fluctuations. The service typically includes refrigerated, frozen, and ultra-low temperature storage, and is applicable to clinical trials, laboratory research, and drug manufacturing.
Published: 2024-09-28
Pages: 82
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now